VERGANI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 5.285
AS - Asia 3.281
EU - Europa 2.327
SA - Sud America 505
AF - Africa 84
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.490
Nazione #
US - Stati Uniti d'America 5.149
SG - Singapore 1.320
IT - Italia 710
CN - Cina 677
VN - Vietnam 389
BR - Brasile 373
RU - Federazione Russa 349
HK - Hong Kong 348
DE - Germania 262
SE - Svezia 198
IE - Irlanda 157
GB - Regno Unito 154
FR - Francia 115
IN - India 114
CA - Canada 78
UA - Ucraina 78
ID - Indonesia 68
BD - Bangladesh 55
ES - Italia 51
AR - Argentina 46
NL - Olanda 46
TR - Turchia 46
AT - Austria 43
FI - Finlandia 43
IQ - Iraq 41
KR - Corea 41
MX - Messico 37
ZA - Sudafrica 34
PL - Polonia 33
PK - Pakistan 31
EC - Ecuador 25
JP - Giappone 25
PH - Filippine 23
BE - Belgio 17
CO - Colombia 17
UZ - Uzbekistan 17
DK - Danimarca 16
SA - Arabia Saudita 14
VE - Venezuela 13
CH - Svizzera 12
JO - Giordania 12
KE - Kenya 9
MA - Marocco 9
NP - Nepal 9
CZ - Repubblica Ceca 8
ET - Etiopia 8
LT - Lituania 8
CL - Cile 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
KZ - Kazakistan 6
JM - Giamaica 5
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TH - Thailandia 5
AU - Australia 4
BO - Bolivia 4
CR - Costa Rica 4
GR - Grecia 4
NG - Nigeria 4
AL - Albania 3
CI - Costa d'Avorio 3
EG - Egitto 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KI - Kiribati 1
MD - Moldavia 1
MN - Mongolia 1
Totale 11.480
Città #
Singapore 778
Ann Arbor 652
Ashburn 475
Fairfield 369
Hong Kong 332
San Jose 321
Woodbridge 280
Dallas 266
Milan 257
Houston 210
Wilmington 208
Chandler 201
Frankfurt am Main 170
New York 164
Dublin 147
Seattle 146
Ho Chi Minh City 121
Cambridge 120
Beijing 116
Santa Clara 111
Dearborn 110
Los Angeles 99
Hanoi 84
Hefei 83
Chicago 72
Jacksonville 72
Princeton 66
São Paulo 61
Jakarta 57
Council Bluffs 46
Lauterbourg 46
Buffalo 45
The Dalles 44
Nanjing 43
Seoul 40
Lawrence 31
Vienna 28
Montreal 26
Warsaw 25
London 23
Moscow 23
Orem 23
Tokyo 23
Amsterdam 22
Pune 22
Besana In Brianza 21
Chennai 21
Denver 21
Rome 21
Baghdad 20
Guangzhou 20
Johannesburg 20
Altamura 19
Da Nang 19
San Diego 19
Shanghai 19
Turin 19
Egg Harbor 17
Nanchang 17
Zhengzhou 17
Munich 16
Nuremberg 16
Brussels 15
Haiphong 15
Helsinki 15
Phoenix 14
San Francisco 14
Tashkent 14
Toronto 14
Atlanta 13
Lahore 13
Stockholm 13
Andover 12
Changsha 12
Ottawa 12
Quito 12
Rio de Janeiro 12
Salt Lake City 12
Bắc Ninh 11
Cinisello Balsamo 11
Desio 11
Lappeenranta 11
Melzo 11
Brooklyn 10
Columbus 10
Hebei 10
Lachine 10
Mexico City 10
Mumbai 10
New Delhi 10
Tianjin 10
Zurich 10
Amman 9
Belo Horizonte 9
Boardman 9
Brasília 9
Dhaka 9
Kent 9
Manchester 9
Shenyang 9
Totale 7.409
Nome #
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 358
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 339
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 332
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 331
TNF-related apoptosis-inducing ligand (trail)-armed exosomes deliver proapoptotic signals to tumor site 324
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors 323
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy 320
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: A case report 314
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 311
Null ABCA3 in humans: Large homozygous ABCA3 deletion, correlation to clinical-pathological findings 302
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells 293
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b 291
Evidence for a role of autoinflammation in early-phase psoriasis 291
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 285
ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling. 282
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma 280
Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3 251
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 250
Complex immune contextures characterise malignant peritoneal mesothelioma: Loss of adaptive immunological signature in the more aggressive histological types 245
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators 243
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 241
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy 240
Miaquant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices 233
Characterization of fast-twitch and slow-twitch skeletal muscles of calsequestrin 2 (CASQ2)-knock out mice: unexpected adaptive changes of fast-twitch muscles only 230
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 228
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3d surrogate microenvironment 227
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response 223
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression 217
Pulmonary resections: Cytostructural effects of different-wavelength lasers versus electrocautery 217
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 216
A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections 211
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 200
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 198
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 187
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis 186
Monkeypox: A Histopathological and Transmission Electron Microscopy Study 185
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 184
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade 182
Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations 177
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors 169
New Techniques:The Use of Fixed-Frozen Tissue in Routine Ultrastructural Evaluation and Immunogold Labeling 166
Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22 164
Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer 160
Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro 158
Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component 158
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma 157
Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis 155
Genetic surfactant dysfunction in newborn infants and children with acute and chronic lung disease 134
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes? 129
Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome 100
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma 75
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 62
Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome 48
Embryonic hematopoietic stem and progenitor cells show differential susceptibility to leukemic transformation upon acquisition of JMML-associated KrasG12D mutation 37
Totale 11.819
Categoria #
all - tutte 37.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 37 60
2021/2022457 58 62 63 19 26 22 16 31 24 29 47 60
2022/2023820 74 212 83 91 33 121 39 39 64 11 35 18
2023/2024701 35 56 16 28 83 201 92 23 51 5 16 95
2024/20251.957 98 211 168 105 215 126 56 69 243 267 135 264
2025/20265.085 582 379 587 559 622 292 768 261 437 519 79 0
Totale 11.819